Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Quantifying Intranasally Administered Deferoxamine in Rat Brain Tissue with Mass Spectrometry.

Kosyakovsky J, Witthuhn BA, Svitak AL, Frey Ii WH, Hanson L, Fine J.

ACS Chem Neurosci. 2019 Oct 1. doi: 10.1021/acschemneuro.9b00436. [Epub ahead of print]

PMID:
31573798
2.

Intranasal Coadministration of a Diazepam Prodrug with a Converting Enzyme Results in Rapid Absorption of Diazepam in Rats.

Rautiola D, Maglalang PD, Cheryala N, Nelson KM, Georg GI, Fine JM, Svitak AL, Faltesek KA, Hanson LR, Mishra U, Coles LD, Cloyd JC, Siegel RA.

J Pharmacol Exp Ther. 2019 Sep;370(3):796-805. doi: 10.1124/jpet.118.255943. Epub 2019 Mar 5.

PMID:
30837282
3.

Intranasal Delivery of A Novel Amnion Cell Secretome Prevents Neuronal Damage and Preserves Function In A Mouse Multiple Sclerosis Model.

Khan RS, Dine K, Bauman B, Lorentsen M, Lin L, Brown H, Hanson LR, Svitak AL, Wessel H, Brown L, Shindler KS.

Sci Rep. 2017 Jan 31;7:41768. doi: 10.1038/srep41768.

4.

Food consumption and activity levels increase in rats following intranasal Hypocretin-1.

Dhuria SV, Fine JM, Bingham D, Svitak AL, Burns RB, Baillargeon AM, Panter SS, Kazi AN, Frey WH 2nd, Hanson LR.

Neurosci Lett. 2016 Aug 3;627:155-9. doi: 10.1016/j.neulet.2016.05.053. Epub 2016 Jun 2.

PMID:
27264485
5.

Intranasal administration of CNS therapeutics to awake mice.

Hanson LR, Fine JM, Svitak AL, Faltesek KA.

J Vis Exp. 2013 Apr 8;(74). doi: 10.3791/4440.

6.

Intranasal delivery of insulin via the olfactory nerve pathway.

Renner DB, Svitak AL, Gallus NJ, Ericson ME, Frey WH 2nd, Hanson LR.

J Pharm Pharmacol. 2012 Dec;64(12):1709-14. doi: 10.1111/j.2042-7158.2012.01555.x. Epub 2012 Jul 4.

PMID:
23146033
7.

Intranasal delivery of deferoxamine reduces spatial memory loss in APP/PS1 mice.

Hanson LR, Fine JM, Renner DB, Svitak AL, Burns RB, Nguyen TM, Tuttle NJ, Marti DL, Panter SS, Frey WH 2nd.

Drug Deliv Transl Res. 2012 Jun;2(3):160-8. doi: 10.1007/s13346-011-0050-2.

PMID:
25786865
8.

Intranasal phosphoramidon increases beta-amyloid levels in wild-type and NEP/NEP2-deficient mice.

Hanson LR, Hafez D, Svitak AL, Burns RB, Li X, Frey WH 2nd, Marr RA.

J Mol Neurosci. 2011 Mar;43(3):424-7. doi: 10.1007/s12031-010-9460-8. Epub 2010 Oct 13.

PMID:
20941644
9.

Inhibition of ligand binding to G protein-coupled receptors by arachidonic acid.

Bordayo EZ, Fawcett JR, Lagalwar S, Svitak AL, Frey WH Jr.

J Mol Neurosci. 2005;27(2):185-94.

PMID:
16186629

Supplemental Content

Loading ...
Support Center